Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

NCT05098990 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Jinfukang oral liquid
DRUG: Platinum-based doublet chemotherapy

Sponsor

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.